<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0"><channel><title><![CDATA[Pharma og biotek - opdatering fra debat og chat uge 2]]></title><description><![CDATA[<p dir="auto">Ambu ' Bavarian Nordic ' Hansa Biopharma ' Genmab ' Novo Nordisk ' Zealand Pharma ' Anavex</p>
<p dir="auto">Helge Larsen gennemgår det sidste nye om virksomhederne inden for pharma og biotek ud fra den kvalificerede debat og chat på <a href="https://proinvestor.com/" rel="nofollow ugc">https://proinvestor.com/</a></p>
<p dir="auto">Disclaimer: Helge Larsen har aktier i Anavex, Genmab, Bavarian Nordic, Zealand Pharma og Novo Nordisk. Videoen er ikke en købs- eller salgsanbefaling.</p>
<p dir="auto"></p><div class="ratio ratio-16x9">
<iframe src="https://www.youtube-nocookie.com/embed/ruevmH2mUFo" title="YouTube video player" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share; fullscreen"></iframe>
</div><p></p>
]]></description><link>https://dev.proinvestor.com/forum/topic/444663/pharma-og-biotek-opdatering-fra-debat-og-chat-uge-2</link><generator>RSS for Node</generator><lastBuildDate>Sat, 27 Jun 2026 22:51:53 GMT</lastBuildDate><atom:link href="https://dev.proinvestor.com/forum/topic/444663.rss" rel="self" type="application/rss+xml"/><pubDate>Fri, 13 Jan 2023 13:58:15 GMT</pubDate><ttl>60</ttl></channel></rss>